IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Other Current Assets Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Other Current Assets
kr3.1m
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Other Current Assets
kr94.4m
CAGR 3-Years
115%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Other Current Assets
kr82.2m
CAGR 3-Years
102%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Other Current Assets
kr63.8m
CAGR 3-Years
55%
CAGR 5-Years
99%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Other Current Assets
kr1m
CAGR 3-Years
-81%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Other Current Assets
kr14.6m
CAGR 3-Years
-8%
CAGR 5-Years
65%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Other Current Assets?
Other Current Assets
3.1m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Other Current Assets amounts to 3.1m SEK.

What is IRLAB Therapeutics AB's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
13%

Over the last year, the Other Current Assets growth was -49%. The average annual Other Current Assets growth rates for IRLAB Therapeutics AB have been 15% over the past three years , 13% over the past five years .

Back to Top